Long-term follow-up of the German post-market study for upper airway stimulation for obstructive sleep apnea
Upper airway stimulation (UAS) is an effective treatment for obstructive sleep apnea (OSA) in positive airway pressure (PAP) failure. Most reports have presented short-term data, so long-term safety and efficacy reports are rare. The German post-market study (G-PMS) has followed approximately 60 pat...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2020
|
| In: |
Sleep and breathing
Year: 2020, Volume: 24, Issue: 3, Pages: 979-984 |
| ISSN: | 1522-1709 |
| DOI: | 10.1007/s11325-019-01933-0 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11325-019-01933-0 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s11325-019-01933-0 |
| Author Notes: | Armin Steffen, Ulrich J. Sommer, Joachim T. Maurer, Nils Abrams, Benedikt Hofauer, Clemens Heiser |
| Summary: | Upper airway stimulation (UAS) is an effective treatment for obstructive sleep apnea (OSA) in positive airway pressure (PAP) failure. Most reports have presented short-term data, so long-term safety and efficacy reports are rare. The German post-market study (G-PMS) has followed approximately 60 patients from three implanting centers for several years. |
|---|---|
| Item Description: | Online publiziert: 4. September 2019 Gesehen am 19.01.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1522-1709 |
| DOI: | 10.1007/s11325-019-01933-0 |